Deciphera Pharmaceuticals, Inc. revenue breakdown overview

Deciphera Pharmaceuticals, Inc. revenue for the last year amounted to 163.36 M USD, the most of which — 159.07 M USD — came from its highest performing source at the moment, Switch Control Kinase Inhibitor Platform, the year earlier bringing 125.50 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Deciphera Pharmaceuticals, Inc. 121.55 M USD, and the year before that — 97.22 M USD.